Page 1 of Clinical Trials for ( Boryung Pharmaceutical Co. AND Ltd ) [SPONSOR-COLLABORATORS], 34 Total Matches

Show/Hide Clinical Trials Which are Not Seeking New Volunteers

1
Completed
Fimasartan (BR-A-657) Single Oral Dose in Healthy Subjects
Last Updated: February 3, 2011
Condition(s): Essential Hypertension
2
Completed
Fimasartan (BR-A-657) Multiple Oral Dose in Healthy Subjects
Last Updated: February 3, 2011
Condition(s): Essential Hypertension
3
Completed
A Study to Evaluate the Effect of Atorvastatin on the Pharmacokinetics of Fimasartan in Healthy Male Volunteers
Last Updated: October 7, 2009
Condition(s): Essential Hypertension
4
Completed
A Study to Assess Food Effect on the Pharmacokinetics of Fimasartan in Healthy Male Volunteers
Last Updated: December 23, 2009
Condition(s): Healthy
5
Completed
Antihypertensive Efficacy and Tolerability and Determine the Adequate Antihypertensive Dosage of Fimasartan in Mild to Moderate Essential Hypertension Patients
Last Updated: June 17, 2009
Condition(s): Hypertension
6
Completed
The Clinical Study to Evaluate the Efficacy and Safety of Fimasartan in Patients With Mild to Moderate Essential Hypertension
Last Updated: January 24, 2012
Condition(s): Hypertension
7
Active, not recruiting
Pharmacokinetics of Megace F and Megace OS Under Fasting and Fed Conditions in Healthy Male Volunteers
Last Updated: December 28, 2011
Condition(s): Cachexia; Anorexia
8
Completed
Administration Time-dependent Antihypertensive Effects of Low Dose Aspirin in Well-controlled Hypertensive Patients
Last Updated: December 14, 2010
Condition(s): Well-controlled Hypertension
9
Completed
A Clinical Trial to Evaluate the Effect of Fimarsartan on Pharmacodynamics, Pharmacokinetics, and the Safety of Warfarin in Healthy Male Volunteers
Last Updated: October 7, 2009
Condition(s): Essential Hypertension
10
Completed
A Study to Evaluate the Safety and Pharmacokinetics After Oral Concurrent Administration of Fimasartan and Hydrochlorothiazide in Healthy Male Volunteers
Last Updated: October 7, 2009
Condition(s): Essential Hypertension
11
Completed
Study to Compare and Assess the Safety and Pharmacokinetic Characteristics After Oral Administration of Fimasartan (BR-A-657∙K) in Healthy Elderly and Young Male Volunteers
Last Updated: November 2, 2009
Condition(s): Essential Hypertension
12
Completed
The Effects of Cilnidipine on Metabolic Syndrome Improvement
Last Updated: August 26, 2008
Condition(s): Hypertension; Metabolic Syndrome X
13
Completed
Cilnidipine Effect on High Blood Pressure and Cerebral Perfusion in Ischemic Stroke Patients With Hypertension
Last Updated: December 11, 2008
Condition(s): Hypertension; Stroke
14
Completed
A Clinical Trial to Compare and Evaluate the Pharmacokinetic Characteristics and the Safety of Fimasartan in Hepatic Impairment Patients and Healthy Volunteers
Last Updated: January 2, 2012
Condition(s): Essential Hypertension; Hepatic Impairment
15
Completed
A Therapeutic Exploratory Clinical Study to Evaluate the Antihypertensive Efficacy of Fimasartan (BR-A-657•K) During 24 Hours in Patients With Mild to Moderate Essential Hypertension
Last Updated: December 14, 2010
Condition(s): Essential Hypertension
16
Recruiting
Clinical Trial to Assess the Immunogenicity and Safety of the Vero Cell-derived JE Vaccine in Korea
Last Updated: December 14, 2010
Condition(s): Japanese Encephalitis
17
Completed
Efficacy, Safety and Pharmacodynamic/Pharmacokinetic Study of Fimasartan (BR-A-657•K)
Last Updated: July 10, 2009
Condition(s): Essential Hypertension
18
Completed
A Study to Evaluate the Effect of Ketoconazole and Rifampicin on the Pharmacokinetics of Fimasartan in Healthy Male Volunteers
Last Updated: October 7, 2009
Condition(s): Essential Hypertension
19
Completed
A Clinical Trial to Compare and Evaluate the Pharmacokinetic Characteristics and the Safety of Fimasartan in Renal Impairment Patients and Healthy Volunteers
Last Updated: January 6, 2012
Condition(s): Renal Impairment
20
Enrolling by invitation
A Multi-center, Randomized, Double-blind Phase III Clinical Trial to Assess and Compare to the Efficacy and Safety of Lafutidine, Famotidine and Omeprazole-referenced in Korean Erosive Esophagitis Patients
Last Updated: December 22, 2011
Condition(s): Erosive Esophagitis

Clinical Trials content is provided directly by the U.S. National Institutes of Health via ClinicalTrials.gov and is not reviewed separately by ClinicalTrialsFeeds.org. Every page of specific clinical trials information contains a unique identifier which can be used to find further details directly from the National Institutes of Health.

The URL of this page is: http://clinicaltrialsfeeds.org/clinical-trials/results/?spons=Boryung+Pharmaceutical+Co.%2C+Ltd

Page 1 of Clinical Trials for ( Boryung Pharmaceutical Co. AND Ltd ) [SPONSOR-COLLABORATORS], 34 Total Matches

Get the Latest Results via Email or RSS

Subscribe via Web Newsreaders

Browse

Clinical Trials Background

About